Determination of specific receptor sites for platelet activating factor in bovine neutrophils
Determination of specific receptor sites for platelet activating factor in bovine neutrophils
复制标题
DOI:
10.2460/ajvr.2004.65.628
复制
发表时间:
2004-05-01
影响因子:
1
通讯作者:
Hancke, JL
中科院分区:
文献类型:
--
作者:
Burgos, RA;Hidalgo, MA;Hancke, JL
Objective - To identity and characterize a platelet activating factor (PAF) receptor in bovine neutrophils by use of radioligand binding, reverse transcription-polymerase chain reaction (RT-PCR) assay, and western blot analysis.Animals - 4 healthy adult cows.Procedure - Bovine neutrophil membranes were isolated for association, dissociation, and saturation binding experiments with PAF labeled with hydrogen 3 (H-3-PAF). The RT-PCR assay was performed with appropriate human primers, and western blot analysis was developed with a polyclonal antibody obtained from a peptide of bovine PAF receptor.Results - Analysis of kinetic binding data supported a single class of PAF receptor. Binding of H-3-PAF to membrane preparations was selectively displaced by PAF and a nonhydrolyzable analogue of guanine triphosphate (Gpp[NH]p) and by lyso-PAF (a biologically inactive analogue of PAF) to a lesser extent. Among other PAF receptor antagonists, 14-deoxyandrographolide and WEB 2086 were the most effective in inhibiting H-3-PAF binding sites in neutrophil membranes; 2 lignans, schisandrin-A and gamma-schisandrin were also effective, but 2 gingkolides (BN52020 and BN52021) only mildly inhibited H-3-PAF binding. Results of RT-PCR assay and western blot analysis of neutrophil crude membranes confirmed the presence of a PAF receptor.Conclusions and Clinical Relevance - Results indicated that bovine neutrophils express only 1 type of PAF receptor, and it is likely that this receptor is involved in inflammatory responses. The most effective PAF antagonists were 14-deoxyandrographolide and WEB 2086; these PAF antagonists may be potentially useful in the treatment of inflammatory processes in cattle.